JW (Cayman) Therapeutics Co Ltd
HKEX:2126
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
Price:
2.55 HKD
3.66%
Updated:
May 20, 2024
JW (Cayman) Therapeutics Co Ltd
Note Receivable
|
JW (Cayman) Therapeutics Co Ltd
Note Receivable Peer Comparison
Comparables:
6160
1801
603392
300122
300896
Competitive Note Receivable Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Note Receivable | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
JW (Cayman) Therapeutics Co Ltd
HKEX:2126
|
Note Receivable
¥13.4m
|
CAGR 3-Years
-29%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Beigene Ltd
HKEX:6160
|
Note Receivable
¥71.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Innovent Biologics Inc
HKEX:1801
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
|
Note Receivable
¥50m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Imeik Technology Development Co Ltd
SZSE:300896
|
Note Receivable
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is JW (Cayman) Therapeutics Co Ltd's Note Receivable?
Note Receivable
13.4m
CNY
13.4m
CNY
Based on the financial report for Dec 31, 2023, JW (Cayman) Therapeutics Co Ltd's Note Receivable amounts to 13.4m CNY.
What is JW (Cayman) Therapeutics Co Ltd's Note Receivable growth rate?
Note Receivable CAGR 5Y
5%
5%
Over the last year, the Note Receivable growth was 0%. The average annual Note Receivable growth rates for JW (Cayman) Therapeutics Co Ltd have been -29% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
